Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1976 1
1982 1
1984 1
1985 1
1987 1
1988 2
1989 1
1990 3
2000 1
2001 1
2002 3
2006 1
2007 2
2008 1
2009 1
2011 1
2014 1
2015 1
2016 3
2017 2
2018 1
2019 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Actualités et perspectives concernant l’immunothérapie en oncologie thoracique.
Mignard X, Chaabane N, Fallet V, Wislez M. Mignard X, et al. Bull Cancer. 2018 Dec;105 Suppl 1:S16-S23. doi: 10.1016/S0007-4551(18)30386-2. Bull Cancer. 2018. PMID: 30595194 Review. French.
ICIs are currently placed early in the course of the treatment of patients with non-small cell lung cancer (NSCLC). In France, approvals have been pronounced for nivolumab and pembrolizumab (anti-PD-1 antibodies) as second-line treatments after chemotherapy in patie …
ICIs are currently placed early in the course of the treatment of patients with non-small cell lung cancer (NSCLC). In France, …
Cardiothoracic manifestations of neuroendocrine tumours.
Mandegaran R, David S, Screaton N. Mandegaran R, et al. Br J Radiol. 2016;89(1060):20150787. doi: 10.1259/bjr.20150787. Epub 2016 Jan 19. Br J Radiol. 2016. PMID: 26781701 Free PMC article. Review.
Pulmonary neuroendocrine tumours represent a range of tumour grade and differentiation characteristics from pre-malignant diffuse neuroendocrine cell hyperplasia, well-differentiated, low-grade carcinoid tumours with excellent outcomes, through to high-grade small- …
Pulmonary neuroendocrine tumours represent a range of tumour grade and differentiation characteristics from pre-malignant diffuse neuroendoc …
Interleukin 32, inflammation and cancer.
Hong JT, Son DJ, Lee CK, Yoon DY, Lee DH, Park MH. Hong JT, et al. Pharmacol Ther. 2017 Jun;174:127-137. doi: 10.1016/j.pharmthera.2017.02.025. Epub 2017 Feb 14. Pharmacol Ther. 2017. PMID: 28223235 Review.
The IL-32 transcript is expressed in various human tissues and organs such as the spleen, thymus, leukocyte, lung, small intestine, colon, prostate, heart, placenta, liver, muscle, kidney, pancreas, and brain. Cytokines are critical components of cell signali …
The IL-32 transcript is expressed in various human tissues and organs such as the spleen, thymus, leukocyte, lung, small intes …
The Regulatory Role of Both MBNL1 and MBNL1-AS1 in Several Common Cancers.
Zhang Q, Wu Y, Chen J, Tan F, Mou J, Du Z, Cai Y, Wang B, Yuan C. Zhang Q, et al. Curr Pharm Des. 2022;28(7):581-585. doi: 10.2174/1381612827666210830110732. Curr Pharm Des. 2022. PMID: 34459372 Review.
MBNL is mainly expressed in skeletal muscle, neuron tissue, thymus, liver, and kidney and plays an important role in the ultimate differentiation of muscle cells and neurons. ...Antisense protein MBNL1- AS1 can inhibit tumor cell proliferation and metastasis in colo …
MBNL is mainly expressed in skeletal muscle, neuron tissue, thymus, liver, and kidney and plays an important role in the ultimate dif …
Thymomas and thymic carcinomas.
Walker AN, Mills SE, Fechner RE. Walker AN, et al. Semin Diagn Pathol. 1990 Nov;7(4):250-65. Semin Diagn Pathol. 1990. PMID: 2284513 Review.
This review discusses epithelial proliferations of the thymus, excluding carcinoid tumor and small cell carcinoma. The clinical features of thymoma, possible etiologic mechanisms, and associated autoimmune and paraneoplastic conditions are summarized b …
This review discusses epithelial proliferations of the thymus, excluding carcinoid tumor and small cell carcinoma …
Lambert-Eaton myasthenic syndrome.
Newsom-Davis J. Newsom-Davis J. Springer Semin Immunopathol. 1985;8(1-2):129-40. doi: 10.1007/BF00197251. Springer Semin Immunopathol. 1985. PMID: 2988146 Review.
The Lambert-Eaton myasthenic syndrome is associated in about 65% of cases with small cell carcinoma, a tumour of neurosecretory origin. It is characterised physiologically by a decrease in the nerve evoked quantal release of acetylcholine, and in the resting …
The Lambert-Eaton myasthenic syndrome is associated in about 65% of cases with small cell carcinoma, a tumour of neuros …
Ectopic pro-opiomelanocortin syndrome.
Beuschlein F, Hammer GD. Beuschlein F, et al. Endocrinol Metab Clin North Am. 2002 Mar;31(1):191-234. doi: 10.1016/s0889-8529(01)00025-1. Endocrinol Metab Clin North Am. 2002. PMID: 12055989 Review.
According to this review, the four most common causes of ectopic POMC syndrome are the small cell carcinoma of the lung (27%), bronchial carcinoids (21%), islet cell tumor of the pancreas (16%), and thymic carcinoids (10%). ...
According to this review, the four most common causes of ectopic POMC syndrome are the small cell carcinoma of the lung …
Small cell cancer of the pleura, kidney, and thymus.
Mirza IA, Shahab N. Mirza IA, et al. Semin Oncol. 2007 Feb;34(1):67-9. doi: 10.1053/j.seminoncol.2006.10.030. Semin Oncol. 2007. PMID: 17270669 Review.
Small cell carcinoma is a distinct clinicopathologic entity that usually arises in the lung but also can originate in extrapulmonary sites, such as the pleura, thymus, and kidney. ...Cisplatin-based chemotherapy has improved the median survival from 8 …
Small cell carcinoma is a distinct clinicopathologic entity that usually arises in the lung but also can originate in e …
Role of Immunotherapy in Small Cell Lung Cancer, Thymic Epithelial Tumors, and Mesothelioma.
Hann CL, Scherpereel A, Hellyer JA, Wakelee HA. Hann CL, et al. Am Soc Clin Oncol Educ Book. 2019 Jan;39:543-552. doi: 10.1200/EDBK_237847. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099677 Free article. Review.
The introduction of programmed death receptor ligand-1 (PD-L1) and programmed death receptor-1 (PD-1) inhibitors into the field of non-small cell lung cancer (NSCLC) was practice changing. The pivotal trials consistently showed a clinically meaningful improvement in …
The introduction of programmed death receptor ligand-1 (PD-L1) and programmed death receptor-1 (PD-1) inhibitors into the field of non-sm …
[Neuroendocrine neoplasms of the mediastinum].
Brcic L, Heidinger M, Popper H. Brcic L, et al. Pathologe. 2016 Sep;37(5):434-40. doi: 10.1007/s00292-016-0198-0. Pathologe. 2016. PMID: 27507161 Review. German.
The WHO classification from 2015 subdivides thymic NETs into three groups; low grade (typical carcinoid), intermediate grade (atypical carcinoid) and high grade (large cell neuroendocrine carcinoma and small cell carcinoma). Through this change …
The WHO classification from 2015 subdivides thymic NETs into three groups; low grade (typical carcinoid), intermediate grade (atypical carci …
34 results